Cyfra 21-1 as a Biologic Marker of Non-small Cell Lung Cancer
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value
![PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bdba421605be5e232b261c12588773538791f229/3-Table4-1.png "PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar")
PDF] Diagnostic Utility of Serum Cytokeratin Fragment 21-1 in Patients with Lung Cancer | Semantic Scholar
KoreaMed Synapse
Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels | Semantic Scholar
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
Brahms Cyfra 21 QC Cyfra21 QC 6 vials (QC1 , QC2 ) Human Cyfra 21-1 and human
CYFRA 21-1 levels (ng·ml -1 ) in lung cancer according to TNM stage | Download Table
Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels | Semantic Scholar
Oncology
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)
Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell Carcinoma of the Oropharnyx | Anticancer Research
TM-CYFRA 21-1 ELISA - DRG International, Inc.
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer - ScienceDirect
Decreased levels of serum cytokeratin 19 fragment CYFRA 21‑1 predict objective response to chemotherapy in patients with non-small cell lung cancer
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect
CYFRA 21-1: a suitable tumor marker in patients with head and neck cutaneous squamous cell carcinoma? | SpringerLink
Cyfra 21-1 Cancer Antigen
Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer - IOS Press
The Korean Journal of Internal Medicine
CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer
CYFRA 21-1 EIA | Fujirebio
![PDF] Usefulness of cyfra 21-1 as a tumor marker of lung cancer by 박현덕(Hyun Duk Park), Hyun-Sik Chung, 박정식(Jeung Sik Park), 임성호(Sung Ho Lim), Eun-Jung Rhee, 윤중원, 정수석(Su Suk Jung), 신호철, 이승세 ·](https://og.oa.mg/Usefulness%20of%20cyfra%2021-1%20as%20a%20tumor%20marker%20of%20lung%20cancer.png?author=%20%EB%B0%95%ED%98%84%EB%8D%95(Hyun%20Duk%20Park),%20Hyun-Sik%20Chung,%20%EB%B0%95%EC%A0%95%EC%8B%9D(Jeung%20Sik%20Park),%20%EC%9E%84%EC%84%B1%ED%98%B8(Sung%20Ho%20Lim),%20Eun-Jung%20Rhee,%20%EC%9C%A4%EC%A4%91%EC%9B%90,%20%EC%A0%95%EC%88%98%EC%84%9D(Su%20Suk%20Jung),%20%EC%8B%A0%ED%98%B8%EC%B2%A0,%20%EC%9D%B4%EC%8A%B9%EC%84%B8 "PDF] Usefulness of cyfra 21-1 as a tumor marker of lung cancer by 박현덕(Hyun Duk Park), Hyun-Sik Chung, 박정식(Jeung Sik Park), 임성호(Sung Ho Lim), Eun-Jung Rhee, 윤중원, 정수석(Su Suk Jung), 신호철, 이승세 ·")